Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets
United Therapeutics Deferred Tax Assets and Other Non-Current Assets increased by 18.4% to $233.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.9%, from $222.40M to $233.20M. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows an upward trend with a 3.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ4 2024
How to read this metric
An increase generally reflects a growing long-term asset base or deferred tax position, while a decrease suggests asset liquidation or tax benefit utilization.
Detailed definition
This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets not classifi...
Peer comparison
Commonly found in the non-current asset section of balance sheets for large, diversified financial firms.
Metric ID:
deferred_tax_assets_other_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $177.00M | $109.00M | $108.20M | $113.30M | $105.80M | $114.80M | $114.30M | $124.50M | $135.30M | $141.70M | $151.80M | $169.10M | $167.90M | $183.60M | $222.10M | $222.40M | $233.30M | $262.60M | $196.90M | $233.20M |
| QoQ Change | — | -38.4% | -0.7% | +4.7% | -6.6% | +8.5% | -0.4% | +8.9% | +8.7% | +4.7% | +7.1% | +11.4% | -0.7% | +9.4% | +21.0% | +0.1% | +4.9% | +12.6% | -25.0% | +18.4% |
| YoY Change | — | — | — | — | -40.2% | +5.3% | +5.6% | +9.9% | +27.9% | +23.4% | +32.8% | +35.8% | +24.1% | +29.6% | +46.3% | +31.5% | +39.0% | +43.0% | -11.3% | +4.9% |
Range$105.80M – $262.60M
CAGR+6.0%
Avg YoY Growth+19.2%
Median YoY Growth+26.0%
Deferred Tax Assets and Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is United Therapeutics's deferred tax assets and other non-current assets?
- United Therapeutics (UTHR) reported deferred tax assets and other non-current assets of $233.20M in Q1 2026.
- How has United Therapeutics's deferred tax assets and other non-current assets changed year-over-year?
- United Therapeutics's deferred tax assets and other non-current assets increased by 4.9% year-over-year, from $222.40M to $233.20M.
- What is the long-term trend for United Therapeutics's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), United Therapeutics's deferred tax assets and other non-current assets has grown at a 3.0% compound annual growth rate (CAGR), from $169.90M to $196.90M.
- What does deferred tax assets and other non-current assets mean?
- The total value of long-term tax assets and other miscellaneous long-term assets.